Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
Compare Balance Sheet Results of Vista Pharma.
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
12.31
13.95
-1.64
-11.76%
Share Warrants & Outstandings
Total Reserve
33.10
9.11
23.99
263.34%
Shareholder's Funds
45.42
23.06
22.36
96.96%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
2.38
0.00
2.38
0.00%
Secured Loans
2.38
0.00
2.38
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-4.37
0.09
-4.46
-4,955.56%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.12
0.00
0.12
0.00%
Total Non-Current Liabilities
-1.87
0.09
-1.96
-2,177.78%
Current Liabilities
Trade Payables
5.59
1.39
4.20
302.16%
Other Current Liabilities
1.74
0.61
1.13
185.25%
Short Term Borrowings
5.02
2.57
2.45
95.33%
Short Term Provisions
0.01
0.00
0.01
0.00%
Total Current Liabilities
12.37
4.57
7.80
170.68%
Total Liabilities
55.92
27.73
28.19
101.66%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
27.18
9.39
17.79
189.46%
Less: Accumulated Depreciation
8.48
8.11
0.37
4.56%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
18.70
1.28
17.42
1,360.94%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
10.14
1.57
8.57
545.86%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.05
0.00
0.05
0.00%
Long Term Loans & Advances
2.12
5.06
-2.94
-58.10%
Other Non Current Assets
0.00
7.26
-7.26
-100.00%
Total Non-Current Assets
31.01
15.17
15.84
104.42%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
8.22
4.41
3.81
86.39%
Sundry Debtors
13.54
6.31
7.23
114.58%
Cash and Bank
0.73
0.06
0.67
1,116.67%
Other Current Assets
0.41
1.08
-0.67
-62.04%
Short Term Loans and Advances
2.00
0.70
1.30
185.71%
Total Current Assets
24.91
12.56
12.35
98.33%
Net Current Assets (Including Current Investments)
12.54
7.99
4.55
56.95%
Total Current Assets Excluding Current Investments
24.91
12.56
12.35
98.33%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
55.92
27.73
28.19
101.66%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
7.40
2.57
4.83
187.94%
Book Value per share (adjusted)
7.38
16.53
-9.15
-55.35%
Annual - Borrowings
Borrowings 7.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -7.04% vs -20.08% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 28.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.03% vs 0.24% in Mar 2024
Annual - Investments
Investments 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 150.00% vs 0.00% in Mar 2024
Annual - Current Assets
Current Assets 24.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.45% vs -1.47% in Mar 2024
